{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:20:33Z","timestamp":1773271233716,"version":"3.50.1"},"reference-count":38,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1507\/endocrj.ej14-0408","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T23:37:25Z","timestamp":1415144245000},"page":"173-182","source":"Crossref","is-referenced-by-count":5,"title":["Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation"],"prefix":"10.1507","volume":"62","author":[{"given":"Tatiana A.","family":"Leonova","sequence":"first","affiliation":[{"name":"Counseling-diagnostic Department of thyroid diseases, Minsk City Clinical Oncologic Dispensary, Minsk 220013, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina M.","family":"Drozd","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Belarusian Medical Academy of Post-Graduate Education, Minsk 220013, Belarus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir A.","family":"Saenko","sequence":"additional","affiliation":[{"name":"Department of Health Risk Control, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Mine","sequence":"additional","affiliation":[{"name":"Biostatistics Section, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Biko","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Wuerzburg, Wuerzburg D-97080, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana I.","family":"Rogounovitch","sequence":"additional","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Takamura","sequence":"additional","affiliation":[{"name":"Department of Global Health, Medicine and Welfare, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Reiners","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Wuerzburg, Wuerzburg D-97080, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Health Risk Control, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"},{"name":"Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","unstructured":"1. Harness J (1997) Childhood Thyroid Carcinoma. In: Clark OH, Duh QY (eds) Textbook of Endocrine Surgery. W.B. Saunders, Philadelphia: 75-81."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Demidchik YE, Demidchik EP, Reiners C, Biko J, Mine M, <i>et al<\/i>. (2006) Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. <i>Ann Surg<\/i> 243: 525-532.","DOI":"10.1097\/01.sla.0000205977.74806.0b"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, <i>et al<\/i>. (1998) Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. <i>Thyroid<\/i> 8: 737-744.","DOI":"10.1089\/thy.1998.8.737"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, <i>et al<\/i>. (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. <i>Eur J Endocrinol<\/i> 154: 787-803.","DOI":"10.1530\/eje.1.02158"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Greenspan SL, Greenspan FS (1999) The effect of thyroid hormone on skeletal integrity. <i>Ann Intern Med<\/i> 130: 750-758.","DOI":"10.7326\/0003-4819-130-9-199905040-00016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, <i>et al<\/i>. (2004) Bone mineral density in hyperthyroidism. <i>Clin Endocrinol<\/i> 61: 466-472.","DOI":"10.1111\/j.1365-2265.2004.02110.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Franklyn JA, Betteridge J, Daykin J, Holder R, Oates GD, <i>et al<\/i>. (1992) Long-term thyroxine treatment and bone mineral density. <i>Lancet<\/i> 340: 9-13.","DOI":"10.1016\/0140-6736(92)92423-D"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Quan ML, Pasieka JL, Rorstad O (2002) Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: a systematic overview of the literature. <i>J Surg Oncol<\/i> 79: 62-69; discussion 69-70.","DOI":"10.1002\/jso.10043"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schneider P, Biko J, Reiners C, Demidchik YE, Drozd VM, <i>et al<\/i>. (2004) Impact of parathyroid status and Ca and vitamin-D supplementation on bone mass and muscle-bone relationships in 208 Belarussian children after thyroidectomy because of thyroid carcinoma. <i>Exp Clin Endocrinol Diabetes<\/i> 112: 444-450.","DOI":"10.1055\/s-2004-821204"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Heemstra KA, Hamdy NA, Romijn JA, Smit JW (2006) The effects of thyrotropin-suppressive therapy on bone metabolism in patients with well-differentiated thyroid carcinoma. <i>Thyroid<\/i> 16: 583-591.","DOI":"10.1089\/thy.2006.16.583"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Schneider R, Reiners C (2003) The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. <i>Exp Clin Endocrinol Diabetes<\/i> 111: 455<i>-<\/i>470.","DOI":"10.1055\/s-2003-44704"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Schneider R, Schneider M, Reiners C, Schneider P (2012) Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. <i>J Clin Endocrinol Metab<\/i> 97: 3926<i>-<\/i>3934.","DOI":"10.1210\/jc.2012-2570"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wojcicka A, Bassett JH, Williams GR (2013) Mechanisms of action of thyroid hormones in the skeleton. <i>Biochim Biophys Acta<\/i> 1830: 3979<i>-<\/i>3986.","DOI":"10.1016\/j.bbagen.2012.05.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sugitani I, Fujimoto Y (2011) Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. <i>Surgery<\/i> 150: 1250<i>-<\/i>1257.","DOI":"10.1016\/j.surg.2011.09.013"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mazokopakis EE, Starakis IK, Papadomanolaki MG,Batistakis AG, Papadakis JA (2006) Changes of bone mineral density in pre<i>-<\/i>menopausal women with differentiated thyroid cancer receiving L<i>-<\/i>thyroxine suppressive therapy. <i>Curr Med Res Opin<\/i> 22: 1369<i>-<\/i>1373.","DOI":"10.1185\/030079906X115612"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Youngwirth L, Benavidez J, Sippel R, Chen H (2010) Postoperative parathyroid hormone testing decreases symptomatic hypocalcemia and associated emergency room visits after total thyroidectomy. <i>Surgery<\/i> 148: 841<i>-<\/i>844; discussion 844-846.","DOI":"10.1016\/j.surg.2010.07.038"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Baldassarre RL, Chang DC, Brumund KT, Bouvet M (2012) Predictors of hypocalcemia after thyroidectomy: results from the nationwide inpatient sample. <em>ISRN Surg<\/em> 2012: 838614, doi: 10.5402\/2012\/838614.","DOI":"10.5402\/2012\/838614"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Reiners C, Biko J, Haenscheid H, Hebestreit H, Kirinjuk S, <i>et al<\/i>. (2013) Twenty<i>-<\/i>five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high<i>-<\/i>risk radiation<i>-<\/i>induced differentiated thyroid carcinoma. <i>J Clin Endocrinol Metab<\/i> 98: 3039<i>-<\/i>3048.","DOI":"10.1210\/jc.2013-1059"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, <i>et al<\/i>. (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. <i>Thyroid<\/i> 19: 1167<i>-<\/i>1214.","DOI":"10.1089\/thy.2009.0110"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Di Daniele N, Carbonelli MG, Candeloro N, Iacopino L, De Lorenzo A, <i>et al<\/i>. (2004) Effect of supplementation of calcium and vitamin D on bone mineral density and bone mineral content in peri<i>-<\/i> and post<i>-<\/i>menopause women; a double<i>-<\/i>blind, randomized, controlled trial. <i>Pharmacol Res<\/i> 50: 637<i>-<\/i>641.","DOI":"10.1016\/S1043-6618(04)00145-8"},{"key":"21","unstructured":"21. Dawson<i>-<\/i>Hughes, B., Harris, S.S., Krall, E.A, Dallal GE (2000) Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. <i>Am J Clin Nutr<\/i> 72: 745<i>-<\/i>750."},{"key":"22","unstructured":"22. Hawkins F, Escobar<i>-<\/i>Jimenez F, Jodar E, Campos MM, Lopez Alvarez MB, <i>et al<\/i>. (2003) Bone mineral density in hypoparathyroid women on LT4 suppressive therapy. Effect of calcium and 1,25(OH)2 vitamin D3 treatment. <i>J Musculoskelet Neuronal Interact<\/i> 3: 71<i>-<\/i>76."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, <i>et al<\/i>. (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. <i>J Bone Miner Res<\/i> 23: 2018<i>-<\/i>2024.","DOI":"10.1359\/jbmr.080803"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Orozco P (2004) Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women. <i>Eur J Epidemiol<\/i> 19: 1105<i>-<\/i>1112.","DOI":"10.1007\/s10654-004-1706-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Tanko LB, Bagger YZ, Nielsen SB, Christiansen C (2003) Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? <i>Bone<\/i> 32: 8<i>-<\/i>14.","DOI":"10.1016\/S8756-3282(02)00918-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Uyama O, Yoshimoto Y, Yamamoto Y, Kawai A (1997) Bone changes and carotid atherosclerosis in postmenopausal women. <i>Stroke<\/i> 28:1730-1732.","DOI":"10.1161\/01.STR.28.9.1730"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Samelson EJ, Cupples LA, Hannan MT, Wilson PW, Williams SA, <i>et al<\/i>. (2004) Long<i>-<\/i>term effects of serum cholesterol on bone mineral density in women and men: the Framingham Osteoporosis Study. <i>Bone<\/i>, 34, 557<i>-<\/i>561.","DOI":"10.1016\/j.bone.2003.11.024"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Solomon DH, Avorn J, Canning CF, Wang PS (2005) Lipid levels and bone mineral density. <i>Am J Med<\/i> 118: 1414.","DOI":"10.1016\/j.amjmed.2005.07.031"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, <i>et al<\/i>. (2003) Correlation between bone mineral density and plasma lipids in Taiwan. <i>Endocr Res<\/i> 29: 317-325.","DOI":"10.1081\/ERC-120025039"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Makovey J, Chen JS, Hayward C, Williams FM, Sambrook PN, <i>et al<\/i>. (2009) Association between serum cholesterol and bone mineral density. <i>Bone<\/i> 44: 208<i>-<\/i>213.","DOI":"10.1016\/j.bone.2008.09.020"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kaur M, Pearson D, Godber I, Lawson N, Baker P, <i>et al<\/i>. (2003) Longitudinal changes in bone mineral density during normal pregnancy. <i>Bone<\/i> 32: 449<i>-<\/i>454.","DOI":"10.1016\/S8756-3282(03)00017-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Promislow JH, Hertz<i>-<\/i>Picciotto I, Schramm M, Watt-Morse M, Anderson JJ (2004) Bed rest and other determinants of bone loss during pregnancy. <i>Am J Obstet Gynecol<\/i> 191: 1077<i>-<\/i>1083.","DOI":"10.1016\/j.ajog.2004.05.058"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zerwekh JE, Ruml LA, Gottschalk F, Pak CY (1998) The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. <i>J Bone Miner Res<\/i> 13:1594-1601.","DOI":"10.1359\/jbmr.1998.13.10.1594"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Moller UK, Vieth Streym S, Mosekilde L, Rejnmark L (2012) Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. <i>Osteoporos Int<\/i> 23: 1213<i>-<\/i>1223.","DOI":"10.1007\/s00198-011-1654-6"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pearson D, Kaur M, San P, Lawson N, Baker P, <i>et al<\/i>. (2004) Recovery of pregnancy mediated bone loss during lactation. <i>Bone<\/i> 34: 570<i>-<\/i>578.","DOI":"10.1016\/j.bone.2003.11.005"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mundy GR, Shapiro JL, Bandelin JG, Canalis EM, Raisz LG <i>et al<\/i>. (1976) Direct stimulation of bone resorption by thyroid hormones. <i>J Clin Invest<\/i> 58: 529<i>-<\/i>534.","DOI":"10.1172\/JCI108497"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ross DS (1994) Hyperthyroidism, thyroid hormone therapy, and bone. <i>Thyroid<\/i> 4: 319<i>-<\/i>326.","DOI":"10.1089\/thy.1994.4.319"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, <i>et al<\/i>. (2005) Lack of deleterious effect on bone mineral density of long<i>-<\/i>term thyroxine suppressive therapy for differentiated thyroid carcinoma. <i>Endocr Relat Cancer<\/i> 12: 973<i>-<\/i>981.","DOI":"10.1677\/erc.1.01072"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T23:36:30Z","timestamp":1498174590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/62\/2\/62_EJ14-0408\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej14-0408","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}